Daniel Wu Washington Post Scientists said the drug trial of the mRNA vaccine for melanoma could be the beginning of a transformation in care.
Daniel Wu is a Staff Writer at various prominent publications, including The Sydney Morning Herald and The Washington Post. He covers a diverse range of topics, with a focus on health and wellness, climate change, and religion, often exploring themes such as aging and longevity, diet and nutrition, and the impact of AI platforms on society. His work has been featured in numerous outlets, including The Seattle Times, The Boston Globe, and The Irish News.